Lateral recumbency after Capromorelin (Entyce) in dogs

The FDA has received 24 reports of lateral recumbency in dogs after Capromorelin. That is 1.6% of all reports for this medicine, compared with 0.3% across reports for all dog medicines, so it is reported unusually often with this medicine.

24Reports
83%Marked serious
21%Recovered
42%Died or euthanised
1 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
9 43%
1–2 days
5 24%
3–7 days
5 24%
1–4 weeks
0 0.0%
Over a month
2 9.5%

How the animals did

Recovered
5 21%
Still unwell when reported
6 25%
Died
2 8.3%
Euthanised
8 33%
Not known
3 13%

Problems reported at the same time

Age of the animals

Under 1 year
2
1–3 years
2
4–7 years
4
8–11 years
3
12+ years
13

About this medicine

Capromorelin stimulates appetite.

Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Capromorelin cause lateral recumbency in dogs?
24 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 1 day of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Lateral recumbency with similar medicines

All reported side effects of Capromorelin in dogs · Medicines most reported with lateral recumbency